Collectively, our data demonstrate that melanocyte-specific loss of Lats1/2 alone, or in conjunction with oncogenic Braf expression, promotes mouse melanocyte transformation and the formation of mouse melanoma. This evidence concerns the gene BRAF and melanoma.